| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.2 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |